Clinical Trial Update: Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating a personalised electronic record-supported optimisation of amlodipine for hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)

Snippet

Sponsor: Queen Mary University of London | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN